News

Cancer Research UK19d
A trial looking at Acelarin and gemcitabine for pancreatic cancer that has spread (ACELARATE)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available. Doctors often use chemotherapy to treat pancreatic cancer that has spread. One of the drugs ...
Cochrane13d
Intravesical gemcitabine for non-muscle invasive bladder cancer
Gemcitabine may reduce the risk of recurrence over time, but may have a similar effect on progression (cancer getting worse) and severe unwanted effects compared to saline. Gemcitabine may prevent ...
ahajournals.org16d
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association ...
Dual antiplatelet therapy is recommended for patients with acute coronary syndromes (ACS). Ticagrelor or prasugrel is recommended in preference to clopidogrel in patients with ACS who are undergoing ...
ahajournals.org16d
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association ...
NSTE-ACS indicates non–ST-segment elevation acute coronary syndromes; PCI, percutaneous coronary intervention; and STEMI, ST-segment elevation myocardial infarction. 4.3.2. Oral P2Y12 Inhibitors ...
Novartis6d
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. - Novartis
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after ...